Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces evoked pain in healthy volunteers, a randomized, double‐blind, placebo‐controlled, crossover study - Segerdahl, M.; Rother, M.; Halldin, M. M.; Popescu, T.; Schaffler, K. (European journal of pain, 2024)
Keywords: Administration, Cutaneous; Administration, Topical; Adult; Analgesics - administration & dosage; Analgesics - pharmacokinetics; Analgesics - pharmacology; Cross-Over Studies; Double-Blind Method; Female; Gels; Healthy Volunteers; Humans; Laser-Evoked Potentials - drug effects; Male; Middle Aged; Pain - drug therapy; Pain Measurement; Skin - drug effects; TRPV Cation Channels - antagonists & inhibitors; Young Adult